GPR39 Receptor Activation Counters Metabolic Liver Disease in Preclinical Mouse Models
Pharmacological activation of the GPR39 receptor with agonist TM-N1324 protected against MASLD and MASH and improved metabolic syndrome features in ...
Pharmacological activation of the GPR39 receptor with agonist TM-N1324 protected against MASLD and MASH and improved metabolic syndrome features in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.